The effect of oral dydrogesterone in supporting the luteal phase in patients undergoing in vitro fertilization treatment

Phase 3

Recruiting

• Conditions: Infertility treated by in Vitro Fertilization.; In vitro fertilization; Z31.2

• Registration Number: IRCT20200421047152N5
• Lead Sponsor: Iranian academic center for education culture and research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 384

Inclusion Criteria

Women between 20-40 years old
with a 5-day frozen embryo created by intracytoplasmic sperm injection (ICSI)
Normal uterine cavity

Exclusion Criteria

Follicle stimulating hormone serum level above 12 FSH milliunits/ml
History of endometriosis
History of moderate to severe adenomyosis
History of 3 or more previously failed embryo transfers
Sex selection cycles
Embryo donation cycles or surrogacy
Hydrosalpinx
Any type of uterine abnormalities (septum, etc.)
Submucousal myoma
Asherman syndrome

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: 5 weeks after embryo transfer. Method of measurement: Trans vaginal ultrasound imaging.

Secondary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: Day 14 after embryo transfer. Method of measurement: Serum levels of beta human chorionic gonadotropin hormone (Beta HCG).;Ongoing pregnancy. Timepoint: 12 weeks after embryo transfer. Method of measurement: Trans abdominal ultrasound imaging.